4.4 Article

Culture Human Mesenchymal Stem Cells With Calcium Phosphate Cement Scaffolds for Bone Repair

Publisher

WILEY
DOI: 10.1002/jbm.b.31563

Keywords

calcium phosphate cement; chitosan; strength and toughness; human mesenchymal stem cells; bone tissue engineering

Funding

  1. NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014190] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017974] Funding Source: NIH RePORTER
  3. NIDCR NIH HHS [R01 DE014190, R01 DE017974, DE14190, R01 DE014190-07A1, R01 DE014190-07A1S1, DE17974] Funding Source: Medline

Ask authors/readers for more resources

Because of its moldability and excellent osteoconductivity, calcium phosphate cement (CPC) is highly promising for craniofacial and orthopedic applications. The objectives of this study were to investigate the response of human mesenchymal stem cells (hMSCs) to a high-strength CPC-chitosan scaffold and to examine cell proliferation and osteogenic differentiation. hMSCs were seeded onto CPC-chitosan composite, CPC control, and tissue culture polystyrene (TOPS). Alkaline phosphatase activity (ALP) and mineralization of hMSCs were measured. CPC-chitosan had a flexural strength (mean +/- SD; n = 5) of (19.5 +/- 1.4) MPa, higher than (8.0 +/- 1.4) MPa of CPC control (p < 0.05). The percentage of live hMSCs on CPC-chitosan was (90.5 +/- 1.3)% at 8 days, matching (90.7 +/- 3.8)% of CPC control (p > 0.1). The CPC-chitosan surface area covered by the attached hMSCs increased from (51 +/- 11)% at 1 day to (90 +/- 4)% at 8 days (p < 0.05), matching those of CPC control (p > 0.1). Hence, the CPC strength was significantly increased via chitosan without compromising the hMSC response. At 8 days, there was a significant increase in ALP of cells in osteogenic media (10.99 +/- 0.93) [(mM pNpp/min)/(mu g DNA)] versus control media (3.62 +/- 0.40) (p < 0.05). hMSCs in osteogenic media exhibited greater mineralization area of (47.5 +/- 19.7)% compared with (6.1 +/- 2.3)% in control medium on TCPS (p < 0.05). In conclusion, hMSCs showed excellent attachment and viability on the strong and tough CPC-chitosan scaffold, matching the hMSC response on CPC control. hMSCs were successfully differentiated down the osteogenic lineage. Hence, the strong, in situ hardening CPC-chitosan scaffold may be useful as a moderate load-bearing vehicle to deliver hMSCs for maxillofacial and orthopedic bone tissue engineering. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 93B: 93-105. 2010

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available